Genetic and Pharmacologic Inhibition of JAK1/2 Antagonizes Cardiac Fibrosis.
作者信息
Meng Qinghang, Yang Bo, Qiao Yan, Wu Yingxin, Chen Jie, Lin Xinhua, Molkentin Jeffery D
机构信息
Center for Organoid and Regeneration Medicine, Greater Bay Area Institute of Precision Medicine (Guangzhou), Guangdong, China (Q.M., B.Y., Y.W., J.C., X.L.).
School of Life Sciences, Fudan University, Shanghai, China (Q.M., B.Y., Y.W., J.C., X.L.).
出版信息
Circulation. 2024 Sep 10;150(11):899-901. doi: 10.1161/CIRCULATIONAHA.124.070340. Epub 2024 Sep 9.
Abstract
摘要
相似文献
1
Genetic and Pharmacologic Inhibition of JAK1/2 Antagonizes Cardiac Fibrosis.JAK1/2的基因和药理学抑制可对抗心脏纤维化。
Circulation. 2024 Sep 10;150(11):899-901. doi: 10.1161/CIRCULATIONAHA.124.070340. Epub 2024 Sep 9.
2
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.接受 JAK1/2 抑制剂治疗的骨髓纤维化患者中的侵袭性 B 细胞淋巴瘤。
Blood. 2018 Aug 16;132(7):694-706. doi: 10.1182/blood-2017-10-810739. Epub 2018 Jun 14.
3
JAK1/2 inhibition impairs the development and function of inflammatory dendritic epidermal cells in atopic dermatitis.JAK1/2 抑制作用可损害特应性皮炎中炎症性树突状表皮细胞的发育和功能。
J Allergy Clin Immunol. 2021 Jun;147(6):2202-2212.e8. doi: 10.1016/j.jaci.2020.11.041. Epub 2020 Dec 15.
4
Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib.通过芦可替尼抑制Janus激酶增强视网膜母细胞瘤对长春新碱的敏感性。
Anticancer Drugs. 2024 Aug 1;35(7):615-622. doi: 10.1097/CAD.0000000000001615. Epub 2024 May 10.
5
JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment.JAK1 依赖性 JAK2 转磷酸化限制了选择性 JAK2 抑制剂在长期治疗中的抗纤维化作用。
Ann Rheum Dis. 2017 Aug;76(8):1467-1475. doi: 10.1136/annrheumdis-2016-210911. Epub 2017 May 6.
6
Pharmacologic blockade of JAK1/JAK2 reduces GvHD and preserves the graft-versus-leukemia effect.对JAK1/JAK2进行药物阻断可减轻移植物抗宿主病并保留移植物抗白血病效应。
PLoS One. 2014 Oct 7;9(10):e109799. doi: 10.1371/journal.pone.0109799. eCollection 2014.
7
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro.一种Jak1/2抑制剂，巴瑞替尼，在体外通过抑制成骨细胞中RANKL的表达来抑制破骨细胞生成。
PLoS One. 2017 Jul 14;12(7):e0181126. doi: 10.1371/journal.pone.0181126. eCollection 2017.
8
Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3.二氨基-1,2,4-三唑衍生物是 TYK2 和 JAK1 的选择性抑制剂，对 JAK2 和 JAK3 的选择性较低。
Bioorg Med Chem Lett. 2010 Dec 15;20(24):7454-7. doi: 10.1016/j.bmcl.2010.10.026. Epub 2010 Oct 13.
9
Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.抗体药物偶联物加 JAK 抑制剂使 MHC 错配的同种异体造血干细胞移植成为可能。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI145501.
10
Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor.JAK1、JAK2和JAK3在成纤维细胞生长因子刺激间充质祖细胞功能活性中的作用
Bull Exp Biol Med. 2016 Dec;162(2):240-243. doi: 10.1007/s10517-016-3585-x. Epub 2016 Dec 1.
引用本文的文献
1
Immune cells and arrhythmias.免疫细胞与心律失常
Cardiovasc Res. 2025 Apr 29;121(3):382-395. doi: 10.1093/cvr/cvaf017.
本文引用的文献
1
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM.成纤维细胞通过细胞外基质协调心脏中的细胞间相互作用。
Nat Cardiovasc Res. 2022 Apr;1(4):312-321. doi: 10.1038/s44161-022-00043-7. Epub 2022 Apr 13.
2
Ruxolitinib Alleviates Renal Interstitial Fibrosis in UUO Mice.罗沙司他减轻 UUO 小鼠的肾间质纤维化。
Int J Biol Sci. 2020 Jan 1;16(2):194-203. doi: 10.7150/ijbs.39024. eCollection 2020.
3
Genetic lineage tracing defines myofibroblast origin and function in the injured heart.遗传谱系追踪定义了心肌梗死后损伤心脏中肌成纤维细胞的起源和功能。
Nat Commun. 2016 Jul 22;7:12260. doi: 10.1038/ncomms12260.
4
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis.芦可替尼与最佳可用疗法治疗骨髓纤维化的 JAK 抑制作用比较。
N Engl J Med. 2012 Mar 1;366(9):787-98. doi: 10.1056/NEJMoa1110556.
5
Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction.通过有机催化氮杂迈克尔反应对Janus激酶抑制剂INCB018424进行对映选择性合成。
Org Lett. 2009 May 7;11(9):1999-2002. doi: 10.1021/ol900350k.
Zotero 插件